Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells


Cyclin E1 is expressed at the G 1/S phase transition of the cell cycle to drive the initiation of DNA replication and is degraded during S/G2M. Deregulation of its periodic degradation is observed in cancer and is associated with increased proliferation and genomic instability. We identify that in cancer cells, unlike normal cells, the closely related protein cyclin E2 is expressed predominantly in S phase, concurrent with DNA replication. This occurs at least in part because the ubiquitin ligase component that is responsible for cyclin E1 downregulation in S phase, Fbw7, fails to effectively target cyclin E2 for proteosomal degradation. The distinct cell cycle expression of the two E-type cyclins in cancer cells has implications for their roles in genomic instability and proliferation and may explain their associations with different signatures of disease.

Type Journal
Authors Caldon, C. E.; Sergio, C.M.; Sutherland, R.L.; Musgrove, E.A.;
Responsible Garvan Author Dr Liz Caldon
Publisher Name CELL CYCLE
Published Date 2013-02-15
Published Volume 12
Published Issue 4
Published Pages 596-605
Status Published in-print
DOI 10.4161/cc.23409
URL link to publisher's version
OpenAccess link to author's accepted manuscript version